Aclaris therapeutics expands leadership team

Wayne, pa., june 27, 2022 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced the appointment of gail cawkwell, md, phd, as chief medical officer, effective today.
ACRS Ratings Summary
ACRS Quant Ranking